Table (1):
Prevalence of neurological manifestations in exposed and control groups
| Neurological manifestations | Studied groups | Z test | P value | |||
|---|---|---|---|---|---|---|
| Exposed (n=100) | Controls (n=50) | |||||
| No. | % | No. | % | |||
| Dizziness | 30 | 30.0 | 6 | 12.0 | 2.23 | 0.02* |
| Headache | 18 | 18.0 | 4 | 8.0 | 1.39 | 0.16 |
| Blurred vision | 27 | 27.0 | 4 | 8.0 | 2.50 | 0.01* |
| Difficulty in concentration | 24 | 24.0 | 5 | 10.0 | 1.83 | 0.03* |
| Impaired memory | 27 | 27.0 | 3 | 6.0 | 2.81 | 0.004* |
| Feeling depressed | 26 | 26.0 | 1 | 2.0 | 3.38 | 0.003* |
| Feeling anxious | 17 | 17.0 | 4 | 8.0 | 1.25 | 0.21 |
| Insomnia | 11 | 11.0 | 2 | 4.0 | 1.13 | 0.25 |
| Fatigue | 31 | 31.0 | 3 | 6.0 | 3.24 | 0.001* |
| Numbness | 13 | 13.0 | 5 | 10.0 | 0.27 | 0.78 |
| Twitches, or involuntary movements in limbs | 7 | 7.0 | 0 | 0.0 | 1.51 | 0.04* |
*
Significant